
About Pharvinex International LLP
Data last updated:
Pharvinex International LLP is a limited liability partnership (LLP) based in Nallasopara, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 April 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAD-7881. Its GSTIN is 27AARFP1102H1ZD (Maharashtra).
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners Sapna Vagesh Tripathi and Vagesh Tripathi.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at A/106 Shreeprastha Complex Aakash Ganga Apartment Nallasopara (West) Palghar District, Maharashtra, India β 401203.
For more details, the LLP can be reached via its website pharvinex.com.
Company details
Contact details
Pharvinex International LLP's registered office is in Nallasopara, Maharashtra.
- Registered AddressA/106 Shreeprastha Complex Aakash Ganga Apartment Nallasopara (West) Palghar District, Maharashtra, India β 401203
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Pharvinex International LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Pharvinex International LLP, buy the company report.
Designated partners of Pharvinex International LLP
Pharvinex International has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sapna Vagesh Tripathi Also directs: Pharvinex Life Science LLP | Designated Partner | 20 Apr 2015 | 11 Years 6 Months | Current |
| Vagesh Tripathi | Designated Partner | 20 Apr 2015 | 11 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Pharvinex International LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharvinex International LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharvinex International has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARFP1102H1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharvinex International LLP, buy the company report.
Recent activity
Pharvinex International LLP has 4 designated partner changes on record since 2015: 2 appointments and 2 cessations. The latest: Chandresh Ghangrekar ceased to be Designated Partner on 31 Mar 2017.
Frequently asked questions
Pharvinex International is an active limited liability partnership based in Nallasopara, Maharashtra, India. The LLP works in api manufacturers, within the pharma industry. It was incorporated on 20 April 2015 (11+ years old) and is registered under LLPIN AAD-7881.
Pharvinex International has 2 current designated partners:
- Sapna Vagesh Tripathi - Designated Partner
- Vagesh Tripathi - Designated Partner
The latest financial statements of Pharvinex International on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Pharvinex International is 27AARFP1102H1ZD, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Pharvinex International is AAD-7881. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Pharvinex International was incorporated on 20 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Chandresh Ghangrekar ceased to be Designated Partner on 31 Mar 2017. Rajina Harischandran ceased to be Designated Partner on 31 Mar 2017. Sapna Vagesh Tripathi was appointed as Designated Partner on 20 Apr 2015. Pharvinex International has 4 designated partner changes on record in total.
Pharvinex International can be reached through the website pharvinex.com. Its registered office is in Nallasopara, Maharashtra, India.
The registered office of Pharvinex International is at A106 Shreeprastha Complex Aakash Ganga Apartment Nallasopara West Palghar District, Maharashtra, India β 401203.
Pharvinex International operates in the pharma industry, in the api manufacturers segment.

